
|Articles|March 20, 2008
DigiFab production increased to combat temporary antibody shortage
Fougera and Protherics announce increased DigiFab production to counteract shortage.
Advertisement
Fougera and Protherics, Inc. have announced an increase in production of their digoxin immune fab (ovine) (
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































